Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD Patients
A United States-based clinical trial is evaluating a non-invasive RECTUM assessment (RECT-US) in a cohort of inflammatory bowel disease pati…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Diet Patterns in IBD in Central Texas
A University of Texas at Austin clinical trial on diet patterns in inflammatory bowel diseases has been suspended, including Crohn's disease…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Boosting Biologics in UC [NA]
Clinical trial at Oslo University Hospital has completed a study investigating biologics for Ulcerative Colitis, part of inflammatory bowel …
-
FDA approval · 2024-04-30FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for ABRILADA (adalimumab-afzb) from Pfizer Laboratories Div Pfizer Inc, authorizing its use as a…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease [NA]
A clinical trial is recruiting to evaluate the effect of probiotic administration on patients with inflammatory bowel disease, including ulc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: T Lymphocyte Subsets in Ulcerative Colitis
Assiut University is conducting a clinical study on T lymphocyte subsets in Ulcerative Colitis, which is currently not yet recruiting.
-
FDA approval · 2024-04-26FDA Approved: RINVOQ — Original Application (AbbVie Inc.)
The FDA approved Rinvoq (upadacitinib) from AbbVie under an Original Application NDA, granting the drug its initial US marketing authorizati…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Fertility and Pregnancy After Surgery IBD Audit
Recruiting clinical trial from the University of Campania Luigi Vanvitelli to study fertility and pregnancy outcomes after surgery in indivi…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Standardized Fecal Microbiota Transplantation for Ulcerative Colitis [Phase 2, Phase 3]
Clinical trial update for standardized fecal microbiota transplantation in ulcerative colitis, currently recruiting in Phase 2 and Phase 3.
-
FDA approval · 2024-04-18FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Entyvio (vedolizumab) from Takeda Pharmaceuticals America, Inc., to modify labeling and expa…
-
FDA approval · 2024-04-18FDA Approved: ENTYVIO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Entyvio (vedolizumab) from Takeda Pharmaceuticals America, resulting in a labeling update fo…
-
CLINICAL_TRIALS withdrawal · 2024-04-18Clinical Trial Update: SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery [Phase 3]
A Phase 3 trial assessing aspirin versus standard of care for VTE prophylaxis after IBD surgery has been withdrawn.
-
FDA approval · 2024-04-16FDA Approved: SELARSDI — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved SELARSDI (USTEKINUMAB-AEKN) from Teva Pharmaceuticals USA, Inc. under an original Biologics License Application (BLA 761343).
-
FDA approval · 2024-04-12FDA Approved: MESALAMINE — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for Mesalamine from Encube Ethicals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy [Phase 3]
Phase 3 trial investigating anti-cytomegalovirus treatment in relapsing ulcerative colitis patients requiring vedolizumab therapy has been t…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients [Phase 2]
Phase 2a study evaluating IcBD-01 enema in active ulcerative colitis is ongoing, status not disclosed.
-
FDA approval · 2024-04-04FDA Approved: MESALAMINE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Mesalamine submitted by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating fecal microbiota transplantation in combination with dietary fiber for ulcerative colitis; results have been posted…
-
FDA approval · 2024-04-01FDA Approved: MESALAMINE — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approves Sun Pharmaceutical Industries' supplemental application for Mesalamine, confirming regulatory approval for this generic product…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice
A real-life practice study evaluating disease control and treatment patterns in moderate to severe inflammatory bowel disease, completed wit…
-
FDA approval · 2024-03-28FDA Approved: MESALAMINE — Supplemental Application (Northstar Rx LLC.)
The FDA approved a supplemental application for Mesalamine submitted by Northstar Rx LLC (ANDA).
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA [Phase 4]
Phase 4 trial update characterizing remission status in ulcerative colitis patients treated with 5-ASA.
-
FDA approval · 2024-03-19FDA Approved: MESALAMINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Mesalamine from Alembic Pharmaceuticals Limited.
-
FDA approval · 2024-03-18FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
A completed clinical trial evaluating the relationship between vedolizumab therapeutic drug monitoring, inflammation biomarkers, and clinica…